Kigawa J - Search Results

1

PTEN expression is associated with prognosis for patients with advanced endometrial carcinoma undergoing postoperative chemotherapy.

Kanamori Y, Kigawa J, Itamochi H, Sultana H, Suzuki M, Ohwada M, Kamura T, Sugiyama T, Kikuchi Y, Kita T, Fujiwara K, Terakawa N. Kanamori Y, et al. Among authors: kigawa j. Int J Cancer. 2002 Aug 20;100(6):686-9. doi: 10.1002/ijc.10542. Int J Cancer. 2002. PMID: 12209607

2

Effect of p53 gene transfer and cisplatin in a peritonitis carcinomatosa model with p53-deficient ovarian cancer cells.

Kigawa J, Sato S, Shimada M, Kanamori Y, Itamochi H, Terakawa N. Kigawa J, et al. Gynecol Oncol. 2002 Feb;84(2):210-5. doi: 10.1006/gyno.2001.6488. Gynecol Oncol. 2002. PMID: 11812076

3

Timing of G-CSF administration based on the circadian rhythm in patients with ovarian cancer.

Sato S, Kigawa J, Irie T, Itamochi H, Kanamori Y, Kamazawa S, Akeshima R, Terakawa N. Sato S, et al. Among authors: kigawa j. Am J Clin Oncol. 2002 Jun;25(3):289-90. doi: 10.1097/00000421-200206000-00018. Am J Clin Oncol. 2002. PMID: 12040291 Clinical Trial.

4

Sensitivity to anticancer agents and resistance mechanisms in clear cell carcinoma of the ovary.

Itamochi H, Kigawa J, Sultana H, Iba T, Akeshima R, Kamazawa S, Kanamori Y, Terakawa N. Itamochi H, et al. Among authors: kigawa j. Jpn J Cancer Res. 2002 Jun;93(6):723-8. doi: 10.1111/j.1349-7006.2002.tb01312.x. Jpn J Cancer Res. 2002. PMID: 12079522 Free PMC article.

5

Mechanisms of cisplatin resistance in clear cell carcinoma of the ovary.

Itamochi H, Kigawa J, Akeshima R, Sato S, Kamazawa S, Takahashi M, Kanamori Y, Suzuki M, Ohwada M, Terakawa N. Itamochi H, et al. Among authors: kigawa j. Oncology. 2002;62(4):349-53. doi: 10.1159/000065067. Oncology. 2002. PMID: 12138243

6

Multidrug resistance gene-1 is a useful predictor of Paclitaxel-based chemotherapy for patients with ovarian cancer.

Kamazawa S, Kigawa J, Kanamori Y, Itamochi H, Sato S, Iba T, Terakawa N. Kamazawa S, et al. Among authors: kigawa j. Gynecol Oncol. 2002 Aug;86(2):171-6. doi: 10.1006/gyno.2002.6738. Gynecol Oncol. 2002. PMID: 12144824

7

Hydrotubation for diagnosing carcinoma in situ of the fallopian tube. A case report.

Takahashi M, Kigawa J, Ishihara K, Shimada M, Kamei T, Terakawa N. Takahashi M, et al. Among authors: kigawa j. Acta Cytol. 2002 Jul-Aug;46(4):735-7. doi: 10.1159/000326986. Acta Cytol. 2002. PMID: 12146042

8

Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary.

Itamochi H, Kigawa J, Sugiyama T, Kikuchi Y, Suzuki M, Terakawa N. Itamochi H, et al. Among authors: kigawa j. Obstet Gynecol. 2002 Aug;100(2):281-7. doi: 10.1016/s0029-7844(02)02040-9. Obstet Gynecol. 2002. PMID: 12151151

9

A feasibility study on biweekly administration of docetaxel for patients with recurrent ovarian cancer.

Oishi T, Kigawa J, Fujiwara K, Fujiwara M, Numa F, Aotani E, Katsumata N, Kohno I, Kato H, Terakawa N; Sankai Gynecology Study Group. Oishi T, et al. Among authors: kigawa j. Gynecol Oncol. 2003 Aug;90(2):421-4. doi: 10.1016/s0090-8258(03)00322-6. Gynecol Oncol. 2003. PMID: 12893211 Clinical Trial.

10

Activity of docetaxel in paclitaxel-resistant ovarian cancer cells.

Sato S, Kigawa J, Kanamori Y, Itamochi H, Oishi T, Shimada M, Iba T, Naniwa J, Uegaki K, Terakawa N. Sato S, et al. Among authors: kigawa j. Cancer Chemother Pharmacol. 2004 Mar;53(3):247-52. doi: 10.1007/s00280-003-0714-9. Epub 2003 Nov 11. Cancer Chemother Pharmacol. 2004. PMID: 14610615

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

189 results

Search Page

Filters